Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 10—October 2022
Research Letter

Cluster of Donor-Derived Cryptococcosis after Liver and Kidney Transplantation

Figures
Tables
Article Metrics
Meng Sha1, Chuan Shen1, Ying TongComments to Author , and Qiang Xia
Author affiliation: Shanghai Jiao Tong University, Shanghai, China

Cite This Article

Abstract

Cryptococcosis infection after transplantation is easily overlooked or misdiagnosed. We report a cluster of donor-derived cryptococcosis infection in liver and kidney transplant recipients from the same donor in China. Infections occurred within 1 month after transplantation, and were confirmed by using biopsies and blood tests.

Cryptococcosis is the third most common invasive fungal infection in solid-organ transplants (1,2). The incidence of cryptococcosis in transplant recipients was estimated to be 0.76% in mainland China, and the Cryptococcus neoformans variant grubii genotype was the predominant species (35).

Cryptococcosis after transplantation is easily overlooked because of high diversity of clinical symptoms, which leads to mortality rates as high as 20% (6). Another feature of recipient-acquired cryptococcosis is the late onset of infection, which usually is 15‒21 months posttransplant (7). However, donor-derived transmission should be considered if disease is found within 1 month posttransplant or if multiple recipients from the same donor become ill (8,9). We report a cluster of donor-derived cryptococcosis after liver and kidney transplantation in China.

This study was approved by the Administration Committee of Shanghai Jiao Tong University, China. Written informed consent was obtained from the patient for the anonymized information to be published in this article.

The transplant donor was a 60-year-old man who had severe cerebral infarction, which progressed to brain death. Chest computed tomography (CT) scan showed clear lung fields and no infiltration. At organ procuring, the liver and kidney grafts looked grossly normal. Routine donor biopsy did not show any histopathologic abnormality. However, retrospective testing of donor serum for cryptococcal antigen (CrAg; Lateral Flow Assay; Immuno-Mycologics, Inc., https://www.immy.com) showed a titer of 1:8 seven days after grafts had been transplanted. One of 2 blood cultures at the time of organ procurement became positive after 8 days of incubation. C. neoformans was subsequently identified.

The first recipient was a 64-year-old man who had hepatocellular carcinoma and underwent liver transplantation. The transplant was successful, and there were no immediate complications. Postoperative aminotransferase levels decreased gradually. However, the recipient had progressive jaundice. The total bilirubin level increased from 103.6 μmol/L on postoperative day (POD) 1 to 704.3 μmol/L on POD 15. The patient had no fevers, cough, or dizziness.

Figure

Transplanted liver tissue biopsy specimen on postoperative day 30 from donor in cluster of donor-derived cryptococcosis, China. A) Hematoxylin and eosin stain shows cryptococcal yeast liver (arrowheads). Original magnification ×200. B) Enlarged view of boxed area from panel A. Original magnification ×400.

Figure. Transplanted liver tissue biopsy specimen on postoperative day 30 from donor in cluster of donor-derived cryptococcosis, China. A) Hematoxylin and eosin stain shows cryptococcal yeast liver (arrowheads). Original magnification ×200....

Liver biopsy on POD 7 showed no evidence of rejection, biliary complications or drug-induced liver injury. The unexpected jaundice persisted and showed no major decrease. Liver biopsy was performed on POD 30. Large numbers of encapsulated yeasts were found inside the liver. Microscopically, the colonized organism had an oval shape and a loose surrounding histiocytic response (Figure). A subsequent recipient serum sample was positive for CrAg (titer >1:2,560) on POD 32.

The recipient received amphotericin B lipid complex plus 5‐flucytosine for 4 weeks. A gradual decrease in bilirubin was observed. The antifungal treatment was changed to oral fluconazole after he was discharged. Follow-up of CrAg showed a decrease from 1:2,560 to 1:32 at 1 year after transplant. Fluconazole was discontinued 15 months after transplant. The recipient showed good liver function for 30 months without active infection (Table). Hepatocellular carcinoma did not recur.

The second recipient was a 65-year-old man who had end-stage renal disease and received a kidney transplant from the same donor. The graft function recovered uneventfully. The recipient was discharged on POD 6 and received an immunosuppression regimen of tacrolimus and mycophenolate. However, the recipient had a low fever and cough on POD 21. Chest CT showed pulmonary consolidations and infiltration. Bronchoalveolar lavage was not performed because intubation was not conducted; there were no signs of hypoxia. However, a CrAg titer of 1:1,280 and positive blood culture resulted in a diagnosis of cryptococcal pneumonia. Antifungal therapy was given for 4 weeks, and oral fluconazole maintenance therapy was given subsequently. The recipient recovered and showed standard graft function and no signs of infection.

The third recipient was a 50-year-old woman who received a kidney transplant from the same donor. She was discharged on POD 6 and had no specific complaints. On POD 26, she reported dizziness, diplopia, and severe headache and was readmitted to the hospital. Fluid from a lumbar puncture culture showed C. neoformans. The serum CrAg titer was >1:2,560. The recipient was given amphotericin B lipid complex and 5‐flucytosine. However, loss of consciousness and a convulsion occurred on POD 31. Further brain CT showed serious cerebral hemorrhage and compression of the brainstem. Her family withdrew care at that point, and the recipient died. Autopsy showed that the glomeruli of the transplanted kidney and spinal cord were infiltrated with oval-shaped yeast consistent with C. neoformans.

The recipients had negative clinical signs and no CrAg pretransplantation. However, the liver and kidney recipients who received organs from the same donor all showed development of cryptococcosis. Cryptococcus sp. in the blood culture and biopsies makes donor-derived transmission the most likely means of infection. Communication gaps between the microbiology laboratories and transplant team were associated with the donor-derived infection of our case. Positive blood culture results should be communicated immediately to initiate antifungal treatment promptly.

Although illnesses and deaths from donor-derived cryptococcosis remain high, results for these case-patients emphasize an increased pretransplant clinical awareness of donor-derived infection. Serum CrAg might identify infected donors and enable effective prophylaxis. In addition, timely communication of suspected results is critical to improve outcomes.

Dr. Sha is a transplant surgeon at Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. His primary research interests are transplant infection and immunity.

Top

Acknowledgments

This study was supported by the National Natural Science Foundation of China (grant 81902379) and National Key Research on Precision Medicine of China (grants 2017YFC0908102 and 2018ZX10723204)

M.S. and C.S. designed the methods, Y.T. and Q.X. conducted the study, M.S. and C.S. wrote the article, and Q.X. supervised the study.

Top

References

  1. Penumarthi  LR, La Hoz  RM, Wolfe  CR, Jackson  BR, Mehta  AK, Malinis  M, et al. Cryptococcus transmission through solid organ transplantation in the United States: A report from the Ad Hoc Disease Transmission Advisory Committee. Am J Transplant. 2021;21:191123. DOIPubMedGoogle Scholar
  2. Singh  N, Sifri  CD, Silveira  FP, Miller  R, Gregg  KS, Huprikar  S, et al. Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes. Transplantation. 2015;99:213241. DOIPubMedGoogle Scholar
  3. Wang  Y, Gu  Y, Shen  K, Cui  X, Min  R, Sun  S, et al. Clinical features of cryptococcosis in patients with different immune statuses: a multicenter study in Jiangsu Province-China. BMC Infect Dis. 2021;21:1043. DOIPubMedGoogle Scholar
  4. Yuchong  C, Fubin  C, Jianghan  C, Fenglian  W, Nan  X, Minghui  Y, et al. Cryptococcosis in China (1985-2010): review of cases from Chinese database. Mycopathologia. 2012;173:32935. DOIPubMedGoogle Scholar
  5. Chen  M, Xu  Y, Hong  N, Yang  Y, Lei  W, Du  L, et al. Epidemiology of fungal infections in China. Front Med. 2018;12:5875. DOIPubMedGoogle Scholar
  6. Baddley  JW, Forrest  GN, Infectious Diseases  AST; AST Infectious Diseases Community of Practice. Cryptococcosis in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13543. DOIPubMedGoogle Scholar
  7. Camargo  JF, Simkins  J, Schain  DC, Gonzalez  AA, Alcaide  ML, Anjan  S, et al. A cluster of donor-derived Cryptococcus neoformans infection affecting lung, liver, and kidney transplant recipients: Case report and review of literature. Transpl Infect Dis. 2018;20:e12836. DOIPubMedGoogle Scholar
  8. Natarajan  P, Lockhart  SR, Basavaraju  SV, Anjan  S, Lindsley  MD, McGrath  MM, et al. Donor-derived Cryptococcus gattii sensu stricto infection in two kidney transplant recipients, southeastern United States. Am J Transplant. 2021;21:37804. DOIPubMedGoogle Scholar
  9. Malinis  M, Boucher  HW, Infectious Diseases  AST; AST Infectious Diseases Community of Practice. Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13548. DOIPubMedGoogle Scholar

Top

Figure
Table

Top

Cite This Article

DOI: 10.3201/eid2810.220522

Original Publication Date: September 09, 2022

1These authors contributed equally to this article.

Table of Contents – Volume 28, Number 10—October 2022

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Ying Tong, Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Send To

10000 character(s) remaining.

Top

Page created: July 31, 2022
Page updated: September 21, 2022
Page reviewed: September 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external